Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 17, 1987 - Issue 6
42
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats

, , , , , & show all
Pages 645-658 | Received 03 Jan 1986, Published online: 30 Sep 2009

References

  • Arima H., Tamazawa K. Synthesis of 14C-labeled indeloxazine hydrochloride (YM-08054), a cerebral activator. Journal of labelled Compounds and Radiopharmaceuticals 1985; 22: 1217–1226
  • Baldwin B. C. Xenobiotic metabolism in plants. Drug Metabolism from Microbe to Man, D. V. Parke, R. L. Smith. Taylor & Francis, London 1977; 191–217
  • Brooks C. J. W., Young L. Biochemical studies of toxic agents. Biochemical Journal 1956; 63: 264–269
  • Case D. E. Incorporation into endogenous metabolic pathways of small fragments derived from I.C.I.58,834 (viloxazine). Xenobiotica 1975; 5: 133–143
  • Case D. E., Reeves P. R. The disposition and metabolism of I.C.I.58,834 (viloxazine) in humans. Xenobiotica 1975; 5: 113–129
  • Case D. E., Illston H., Reeves P. R., Shuker B., Simons P. The disposition and metabolism of I.C.I.58,834 (viloxazine) in animals. Xenobiotica 1975; 5: 83–111
  • Damani L. A., Crooks P. A. Oxidative metabolism of heterocyclic ring systems. Metabolic basis of detoxication, metabolism of functional groups, W. B. Jakoby, J. R. Bend, J. Caldwell. Academic Press, New York 1982; 69–89
  • Harada M., Maeno H. Biochemical characteristics of a potential antidepressant, 2-(7-indenyloxymethyl(morpholine hydrochloride (YM-08054–1). Biochemical Pharmacology 1979; 28: 2645–2651
  • Hayashi T., Sato M., Ohki M., Kishikawa T. Metabolism of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinonc (M73101), a new anti-inflammatory agent. I. Identification of the metabolites in rabbit and their pharmacological studies. Chemical and Pharmaceutical Bulletin 1978; 26: 3124–3134
  • Kamimura H., Sasaki H., Yokoi K., Kawamura S. Determination of indeloxazine in plasma by liquid chromatography and gas chromatography-mass spectrometry. Journal of Pharmaceutical Sciences 1985; 74: 559–561
  • Kojima T., Nhgata K., Fujikura T., Tachikawa S., Nozaki Y., Kagami S., Takahashi K. Syntheses of (±)-2- [(inden-7-yloxy)methyl]merpholine hydrochloride (YM-08054, indeloxazine hydrochloride) and its derivatives with potential cerebral activating and antidepressive properties. Chemical and Pharmaceutical Bulletin 1985; 33: 3766–3774
  • Kucharczyk N., Yang J. T., Valia K. H., Stiefel F. J., Sofia R. D. Metabolites of 2-(3-trifluoromethylphenyl)tetrahydro-1, 4-oxazine (CERM 1841) in rats and dogs. Xenobiotica 1979; 11: 703–711
  • Leibman K. C., Ortiz E. Oxidation of indene in liver microsomes. Molecular Pharmacology 1968; 4: 201–207
  • Lewis D. A. The metabolism of cis- and trans-indane-1,2-diol. Biochemical Journal 1966; 99: 694–702
  • Lewis D. A. Observations on the metabolism of cis- and trans-indane-1,2-diols. Biochemical Pharmacology 1970; 19: 2389–2391
  • Murase K., Niigata K., Mase T., Murakami M. Synthesis of new indene derivatives with β-adrenergic blocking properties. Yakugaku Zasshi 1972; 92: 1358–1363
  • Pitts J. E., Bruce R. B., Forehand J. B. Identification of doxapram metabolites using high pressure ion exchange chromatography and mass spectroscopy. Xenobiotica 1973; 3: 73–83
  • Smith J. N. Comparative detoxication of invertebrates. Drug Metabolism from Microbe to Man, D. V. Parke, R. L. Smith. Taylor & Francis, London 1977; 219–232
  • Tachikawa T., Harada M., Maeno H. Pharmacological and biochemical studies on a new compound, 2-(7-indenyloxymethyl(morpholine hydrochloride (YM-08054–1), and its derivatives with potential cerebral activating and antidepressant properties. Archives Internationales de Pharmacodynamie et de Thérapie 1979; 238: 81–95
  • Tanaka A., Tokieda T., Nambara S., Osawa M., Yamaha T. Excretion and distribution of morpholine salts in rats. Journal of Food Hygienic Society of Japan 1978; 19: 329–334
  • Yamamoto M., Shimizu M. Cerebral activating properties of indeloxazine hydrochloride. Neuropharmacology 1987a, in press
  • Yamamoto M., Shimizu M. Effects of indeloxazine hydrochloride (YM-08054) on anoxia. Archives Internationales de Pharmacodynamie et de Therapie 1987b; 286: 272–281

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.